Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
Wilderness & Environmental Medicine|December 23, 2008
Manual assessment of the initial fall in blood pressure after orthostatic challenge at high altitudeOliver T Mytton, Alistair Simpson, Alfred A R Thompson, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 25, 2025
HLA haplotype diversity, islet autoantibody status and discriminative ability of type 1 diabetes genetic risk score in IndiansAlagu Sankareswaran, Pooja Kunte, Diane P Fraser, et al.
Science (New York, N.Y.)|July 30, 2021
Preventing type 1 diabetes in childhoodColin M Dayan, Rachel E J Besser, Richard A Oram, et al.
Diabetes|May 22, 2016
Type 1 Diabetes Genetic Risk Score: A Novel Tool to Discriminate Monogenic and Type 1 DiabetesK A Patel, R A Oram, S E Flanagan, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 29, 2025
Testing methods used to predict disease progression in children with early-stage type 1 diabetes: A systematic review and meta-analysisRabbi Swaby, Kruthika Narayan, Claire Scudder, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 19, 2022
Capturing the real-world benefit of residual β-cell function during clinically important time-periods in established Type 1 diabetesGuy S Taylor, Andy C Shaw, Kieran Smith, et al.
Diabetologia|October 15, 2013
The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cellsRichard A Oram, Angus G Jones, Rachel E J Besser, et al.
Diabetes|November 12, 2024
Type 1 Diabetes Genetic Risk Contributes to Phenotypic Presentation in Monogenic Autoimmune DiabetesAmber M Luckett, Gareth Hawkes, Harry D Green, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 17, 2011
Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetesA G Jones, R E J Besser, T J McDonald, et al.
Diabetologia|April 11, 2019
Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetesNicholas J Thomas, Anita L Lynam, Anita V Hill, et al.
Pageof 13